Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Current Leases (2021 - 2025)

Historic Current Leases for Coeptis Therapeutics Holdings (COEPW) over the last 5 years, with Q3 2025 value amounting to $29865.0.

  • Coeptis Therapeutics Holdings' Current Leases rose 20197.17% to $29865.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $29865.0, marking a year-over-year increase of 20197.17%. This contributed to the annual value of $42305.0 for FY2024, which is 1119.14% up from last year.
  • As of Q3 2025, Coeptis Therapeutics Holdings' Current Leases stood at $29865.0, which was up 20197.17% from $21738.0 recorded in Q2 2025.
  • Coeptis Therapeutics Holdings' Current Leases' 5-year high stood at $42305.0 during Q1 2024, with a 5-year trough of $9890.0 in Q3 2024.
  • Over the past 5 years, Coeptis Therapeutics Holdings' median Current Leases value was $30713.0 (recorded in 2023), while the average stood at $28023.1.
  • Data for Coeptis Therapeutics Holdings' Current Leases shows a peak YoY increase of 20197.17% (in 2025) and a maximum YoY decrease of 2390.73% (in 2025) over the last 5 years.
  • Coeptis Therapeutics Holdings' Current Leases (Quarter) stood at $14724.0 in 2021, then skyrocketed by 182.65% to $41618.0 in 2022, then dropped by 8.58% to $38047.0 in 2023, then grew by 11.19% to $42305.0 in 2024, then decreased by 29.41% to $29865.0 in 2025.
  • Its last three reported values are $29865.0 in Q3 2025, $21738.0 for Q2 2025, and $32191.0 during Q1 2025.